Linking the relation between gut microbiota and glucocorticoid-induced osteoporosis
Authors:
- 13 March 2023
- journal article
- review article
- Published by Springer Nature in Journal of Bone and Mineral Metabolism
- Vol. 41 (2) , 145-162
Abstract
Osteoporosis (OP) is the most prevalent metabolic bone disease, characterized by the low bone mass and microarchitectural deterioration of bone tissue. Glucocorticoid (GC) clinically acts as one of the anti-inflammatory, immune-modulating, and therapeutic drugs, whereas the long-term use of GC may cause rapid bone resorption, followed by prolonged and profound suppression of bone formation, resulting in the GC-induced OP (GIOP). GIOP ranks the first among secondary OP and is a pivotal risk for fracture, as well as high disability rate and mortality, at both societal and personal levels, vital costs. Gut microbiota (GM), known as the “second gene pool” of human body, is highly correlated with maintaining the bone mass and bone quality, and the relation between GM and bone metabolism has gradually become a research hotspot. Herein, combined with recent studies and based on the cross-linking relationship between GM and OP, this review is aimed to discuss the potential mechanisms of GM and its metabolites on the OP, as well as the moderating effects of GC on GM, thereby providing an emerging thought for prevention and treatment of GIOP.Keywords
Funding Information
- Winfast Charity Foundation Project (YL20220525)
- Jiangsu Elderly Health Research Project, Key Project of Elderly Health Research Project (LKZ2022010)
- Open Project of National Key Professional Base for Standardized Training of Resident Physicians in Zhongda Hospital Affiliated to Southeast University (ZDZYJD-QK-2022-7)
This publication has 143 references indexed in Scilit:
- Effects of a Multispecies Probiotic Supplement on Bone Health in Osteopenic Postmenopausal Women: A Randomized, Double-blind, Controlled TrialJournal of the American College of Nutrition, 2017
- Gut Microbiome and Bone: to Build, Destroy, or Both?Current Osteoporosis Reports, 2017
- Alterations to the Gut Microbiome Impair Bone Strength and Tissue Material PropertiesJournal of Bone and Mineral Research, 2017
- Feedback control of AHR signalling regulates intestinal immunityNature, 2017
- 1H NMR-based metabonomic study on the effects of Epimedium on glucocorticoid-induced osteoporosisJournal of Chromatography B, 2016
- From the gut to the strut: where inflammation reigns, bone abstainsJournal of Clinical Investigation, 2016
- Sex steroid deficiency–associated bone loss is microbiota dependent and prevented by probioticsJournal of Clinical Investigation, 2016
- IGF-I Signaling in Osterix-Expressing Cells Regulates Secondary Ossification Center Formation, Growth Plate Maturation, and Metaphyseal Formation During Postnatal Bone DevelopmentJournal of Bone and Mineral Research, 2015
- Gut microbiota-bone axisCritical Reviews in Food Science and Nutrition, 2015
- Connexin 43 Channels Protect Osteocytes Against Oxidative Stress–Induced Cell DeathJournal of Bone and Mineral Research, 2013